Target intelligence / Profile preview

Damaged gastrointestinal mucosal proteins

Molecular classification
Other
01

Overview

Damaged gastrointestinal mucosal proteins refer to the collection of proteins, such as albumin and fibrinogen, that become exposed at the site of erosions or ulcers in the gastrointestinal tract. These proteins serve as a therapeutic target for cytoprotective agents like sucralfate, which is a sucrose sulfate-aluminum complex. In the acidic environment of the stomach, sucralfate undergoes cross-linking to form a viscous, sticky paste that selectively binds to the positively charged proteins in the ulcer base. This interaction creates a physical barrier that shields the underlying tissue from the corrosive effects of gastric acid, pepsin, and bile salts, thereby facilitating the natural healing process of the mucosa. While not a single receptor or enzyme, these exposed proteins are critical for the localized action of specific gastroprotective medications.

Other names
Ulcerated mucosal proteinsExposed gastrointestinal proteinsExposed albumin and fibrinogenUlcer base proteins
02

Mechanism of action

Formation of a physical barrier through ionic binding to positively charged proteins (such as albumin and fibrinogen) exposed at the site of mucosal damage, protecting the area from further degradation by gastric acid, pepsin, and bile salts.

03

Biological functions

Structural integrityMucosal protection
04

Disease associations

Peptic ulcer diseaseGastritisGastroesophageal reflux disease (GERD)Stress-induced mucosal injury
05

Safety considerations

Aluminum accumulation in patients with chronic renal failureConstipationBezoar formationImpaired absorption of co-administered drugs (e.g., phenytoin, digoxin, fluoroquinolones)
06

Interacting drugs

Sucralfate

1 more in the full profile.

07

Biomarkers

Endoscopic visualization of gastric/duodenal ulcersFecal occult blood test

Beyond the preview

Go deeper on Damaged gastrointestinal mucosal proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Damaged gastrointestinal mucosal proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call